Clopidogrel (Cat No.:I000517) is an antiplatelet medication used to reduce the risk of blood clots in patients with cardiovascular diseases. It belongs to the class of drugs known as thienopyridine derivatives. Clopidogrel works by irreversibly inhibiting the P2Y12 receptor on platelets, which prevents platelet aggregation and reduces the formation of blood clots. It is commonly prescribed to patients with a history of myocardial infarction, stroke, or peripheral artery disease. Clopidogrel is often used in combination with aspirin for enhanced antiplatelet effects and is an essential component of preventive therapy in cardiovascular medicine.
| Catalog Number | I000517 |
| CAS Number | 113665-84-2 |
| Molecular Formula | C16H16ClNO2S |
| Purity | ≥95% |
| Target | P2Y12 receptor |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20C |
| IUPAC Name | methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate |
| InChI | InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 |
| InChIKey | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
| SMILES | COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3 |
| Reference | 1: Ford NF. The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway. J Clin |
